Bromoantimonates
{{Short description|Chemical compounds}}
Bromoantimonates are compounds containing anions composed of bromide (Br−) and antimony (Sb). They can be considered as double bromides, metallohalides or halometallates. They are in the category of halopnictates. Related compounds include the bromobismuthates, iodoantimonates, bromophosphates, and bromoarsenates.
Some examples of bromoantimonates
Bromoantimonates can have antimony in one of two oxidation states, either +3 or +5. These are designated by bromoantimonate(III) or bromoantimonate(V). Although antimony tribromide is known, SbBr5 on its own does not exist, despite the existence of {{chem2|SbBr6−}}.{{cite journal |last1=Holmes |first1=Robert R. |title=Pressure measurements in the arsenic trichloride-chlorine system and the arsenic and antimony tribromide-bromine systems |journal=Journal of Inorganic and Nuclear Chemistry |date=October 1961 |volume=19 |issue=3–4 |pages=363–366 |doi=10.1016/0022-1902(61)80126-7}} Compounds containing both Sb(III) and Sb(V) are mixed valence compounds. The antimony can be linked into chains, (which are called one-dimensional as it is like a line), or in pairs as Sb2 or singly as Sb (which are called zero-dimensional, as the anions are just point-like).
Tetrabromoantimonate(III) (SbBr4−) has single antimony atoms in each anion.{{cite thesis |last1=Ballard |first1=George Jack |title=Spectroscopic Studies of Antimony III and V Halide Complexes |url=https://macsphere.mcmaster.ca/handle/11375/8649 |language=en |date=July 1977}}
SbBr52− contains infinite chains of SbBr6 octahedra linked by corners.{{Cite journal |last1=Bukvetskii |first1=B. V. |last2=Sedakova |first2=T. V. |last3=Mirochnik |first3=A. G. |date=April 2009 |title=Crystal structure and luminescence of antimony(III) bromide with aniline |url=http://link.springer.com/10.1007/s10947-009-0044-9 |journal=Journal of Structural Chemistry |language=en |volume=50 |issue=2 |pages=322–327 |doi=10.1007/s10947-009-0044-9 |bibcode=2009JStCh..50..322B |s2cid=95792428 |issn=0022-4766|url-access=subscription }}
Hexabromoantimonate(III) SbBr63− also exists, forming zero-dimensional compounds.{{Cite journal |last1=Okuda |first1=Tsutomu |last2=Tanaka |first2=Nobuhiko |last3=Ichiba |first3=Sumio |last4=Yamada |first4=Koji |date=1986-02-01 |title=Nuclear Quadrupole Resonance in Chloro- and Bromoantimonate(III) Complexes |journal=Zeitschrift für Naturforschung A |language=en |volume=41 |issue=1–2 |pages=319–325 |doi=10.1515/zna-1986-1-259 |bibcode=1986ZNatA..41..319O |s2cid=3515103 |issn=1865-7109|doi-access=free }}
Nonabromodiantimonate(III) Sb2Br93− has a pair of octahedra of SbBr6 sharing a face. The angles formed by shared bromine at the antimony are reduced from the theoretical 90° to about 80°.{{cite journal |last1=Porter |first1=S. K. |last2=Jacobson |first2=R. A. |title=Crystal structure of pyridinium nonabromodiantimonate(III) dibromide |journal=Journal of the Chemical Society A: Inorganic, Physical, Theoretical |date=1970 |pages=1359 |doi=10.1039/J19700001359}}
Hexabromoantimonate(V) SbBr6− exists in equilibrium with SbBr4− and Br2 but real +5 oxidation state bromoantimonates exist even if SbBr5 is unstable and does not exist.{{cite journal |last1=Kolditz |first1=Lothar |last2=Schiller |first2=Wolfgang |title=Über Hexabromoantimonat |journal=Zeitschrift für anorganische und allgemeine Chemie |date=May 1969 |volume=366 |issue=3–4 |pages=163–168 |doi=10.1002/zaac.19693660307}}{{cite journal |last1=Adams |first1=C.J. |last2=Downs |first2=A.J. |date=June 1972 |title=Features of the coordination chemistry of B-metals—II Bromoantimonates(V) |journal=Journal of Inorganic and Nuclear Chemistry |volume=34 |issue=6 |pages=1829–1840 |doi=10.1016/0022-1902(72)80530-X}}{{cite journal |last1=Schmidtke |first1=Hans-Herbert |last2=Krause |first2=Barbara |last3=Schönherr |first3=Thomas |title=Optical Spectra of Hexahalogeno-Antimony (III) Complex Compounds |journal=Berichte der Bunsengesellschaft für physikalische Chemie |date=June 1990 |volume=94 |issue=6 |pages=700–703 |doi=10.1002/bbpc.19900940614}}
Intersecting classes are nonahalogenodiantimon(III)ates. Hexahaloantimonate(III) ions (SbX63−) can include chlorine or iodine as well as bromine.{{cite journal |last1=Jha |first1=N.K. |last2=Kumari |first2=Amrita |last3=Prasad |first3=R.S. |title=Mixed hexahaloantimonates(III) |journal=Journal of Inorganic and Nuclear Chemistry |date=January 1981 |volume=43 |issue=11 |pages=3016–3019 |doi=10.1016/0022-1902(81)80670-7}}
Related classes include halogeno-oxydiantimon(III)ates, and pentabromothio-diantimonates.{{cite journal |last1=Müller |first1=Ulrich |last2=Mohammed |first2=Abdulalah T. |title=Pentabromothio-diarsenat und -diantimonat: Darstellung, Schwingungsspektren und Kristallstrukturen von PPh4[As2SBr5] und PPh4[Sb2SBr5] |journal=Zeitschrift für anorganische und allgemeine Chemie |date=February 1986 |volume=533 |issue=2 |pages=65–72 |doi=10.1002/zaac.19865330209}} Bromo-phenylantimonates(V) ({{chem2|[C6H5\sSbBr5]-}}) have a phenyl group substituting for one bromine atom.{{cite journal |last1=Bertazzi |first1=N. |last2=Airoldi |first2=Marta |last3=Pellerito |first3=L. |title=Complexes of organometallic compounds : XLIII. Synthesis and infrared spectra of fluoro-, chloro- and bromo-phenylantimonates(V)|journal=Journal of Organometallic Chemistry |date=September 1975 |volume=97 |issue=3 |pages=399–403 |doi=10.1016/S0022-328X(00)89306-7}}
Chlorobromoantimonates(V) have some chlorine instead of bromine.{{cite journal |last1=Bentley |first1=F. F. |last2=Finch |first2=Arthur |last3=Gates |first3=P. N. |last4=Ryan |first4=F. J. |title=Existence of chlorobromoantimonates |journal=Inorganic Chemistry |date=February 1972 |volume=11 |issue=2 |pages=413–414 |doi=10.1021/ic50108a042}}
The antimonide bromides are distinct as they do not have a bond between antimony and bromine. Tetrabromostibonium(V) contains cations ({{chem2|SbBr4+}}) rather than anions.{{cite journal |last1=Casteel |first1=William J. |last2=Kolb |first2=Peter |last3=LeBlond |first3=Nicolas |last4=Mercier |first4=Hélène P. A. |last5=Schrobilgen |first5=Gary J. |title=Tetrachloro- and Tetrabromostibonium(V) Cations: Raman and 19 F, 121 Sb, and 123 Sb NMR Spectroscopic Characterization and X-ray Crystal Structures of SbCl 4 + Sb(OTeF 5 ) 6 - and SbBr 4 + Sb(OTeF 5 ) 6 - |journal=Inorganic Chemistry |date=1 January 1996 |volume=35 |issue=4 |pages=929–942 |doi=10.1021/ic950818z|pmid=11666267 }}
Preparation
Bromoantimonates can be made using a water solution of antimony tribromide, hydrobromic acid, and an amine. Alternately antimony trioxide can be used. Variants can be made without using water, and heating the antimony tribromide with an amine hydrobromide.{{Cite journal |last1=Jha |first1=N.K. |last2=Rizvi |first2=S.S.A. |date=January 1976 |title=Preparative investigations of bromoantimonates(III) |url=https://linkinghub.elsevier.com/retrieve/pii/0022190276802710 |journal=Journal of Inorganic and Nuclear Chemistry |language=en |volume=38 |issue=3 |pages=401–405 |doi=10.1016/0022-1902(76)80271-0|url-access=subscription }}
Some properties
Most of the bromoantimonate salts are yellow or orange.{{Cite journal |last1=Bujak |first1=Maciej |last2=Zarychta |first2=Bartosz |last3=Kobel |first3=Aleksandra |last4=Zaleski |first4=Jacek |date=2004-03-01 |title=Preparation, Crystal Structure at 298 and 90 K and Phase Transition in (C 2 H 5 NH 3 ) 2 [SbBr 5 ] Studied by the Single Crystal X-Ray Diffraction Method |journal=Zeitschrift für Naturforschung B |language=en |volume=59 |issue=3 |pages=298–304 |doi=10.1515/znb-2004-0311 |s2cid=100724080 |issn=1865-7117|doi-access=free }}
For {{chem2|SbBr4-}} there are absorption bands at 224, 300, 245 and 216 nm. {{chem2|SbBr6(3-)}} has absorption bands centred on 359, 311, and 266 nm.{{cite journal |last1=Oldenburg |first1=Karin |last2=Vogler |first2=Arnd |title=Electronic Spectra and Photochemistry of Tin(II), Lead(II), Antimony(III), and Bismuth(III) Bromide Complexes in Solution |journal=Zeitschrift für Naturforschung B |date=1 November 1993 |volume=48 |issue=11 |pages=1519–1523 |doi=10.1515/znb-1993-1109|s2cid=35186839 |doi-access=free }}
Many alkylammonium salts are known. These can have different solid phases at different temperatures, as the alkyl group varies in disorder. Those with longer alkyl chains have a greater number of solid state phases.{{Cite journal |last1=Tarasiewicz |first1=J. |last2=Jakubas |first2=R. |last3=Zaleski |first3=J. |last4=Baran |first4=J. |date=March 2008 |title=Structural characterization, thermal, dielectric and spectroscopic properties of di(n-pentylammonium) pentabromoantimonate(III): [n-C5H11NH3]2[SbBr5] |url=https://linkinghub.elsevier.com/retrieve/pii/S002228600700436X |journal=Journal of Molecular Structure |language=en |volume=876 |issue=1–3 |pages=86–101 |doi=10.1016/j.molstruc.2007.06.005|bibcode=2008JMoSt.876...86T |url-access=subscription }}
Methyl ammonium compounds are ferroelectric.
The infrared spectrum includes wavenumbers (ν/c) of 110 to 130 cm−1 for the bridging bromine in Sb2Br9 and 135 to 220 cm−1 for non-bridging bromine to antimony stretching.{{cite journal |last1=Jagodzinski |first1=Paul W. |last2=Laane |first2=Jaan |title=Low frequency vibrational spectra of bromo-and iodoantimonates |journal=Journal of Raman Spectroscopy |date=February 1980 |volume=9 |issue=1 |pages=22–27 |doi=10.1002/jrs.1250090107|bibcode=1980JRSp....9...22J }}
Bond lengths in SbBr6− are 2.65 and 2.56 Å. In SbBr63− the lengths are greater, from 2.787 to 2.713 Å.
Use
Bromoantimonates are researched for use in photovoltaics,{{cite journal |last1=Thomas |first1=Ankit Stephen |title=A Review on Antimony-based Perovskite Solar Cells |journal=Equilibrium Journal of Chemical Engineering |date=16 October 2022 |volume=6 |issue=2 |pages=75–91 |doi=10.20961/equilibrium.v6i2.64322 |s2cid=255740163 |url=https://jurnal.uns.ac.id/equilibrium/article/view/64322/37693https://jurnal.uns.ac.id/equilibrium/article/view/64322/37693 |language=en |issn=2622-3430|doi-access=free }} X-ray detectors,{{Cite journal |last1=Fan |first1=Qingshun |last2=Xu |first2=Haojie |last3=You |first3=Shihai |last4=Ma |first4=Yu |last5=Liu |first5=Yi |last6=Guo |first6=Wuqian |last7=Hu |first7=Xinxin |last8=Wang |first8=Beibei |last9=Gao |first9=Changhao |last10=Liu |first10=Wei |last11=Luo |first11=Junhua |last12=Sun |first12=Zhihua |date=2023-04-22 |title=Centimeter-Sized Single Crystals of Dion-Jacobson Phase Lead-Free Double Perovskite for Efficient X-ray Detection |url=https://onlinelibrary.wiley.com/doi/10.1002/smll.202301594 |journal=Small |volume=19 |issue=34 |pages=e2301594 |language=en |doi=10.1002/smll.202301594 |pmid=37086129 |s2cid=258275973 |issn=1613-6810|url-access=subscription }} and LEDs.{{Cite journal |last1=Liu |first1=He |last2=Shonde |first2=Tunde Blessed |last3=Gonzalez |first3=Fabiola |last4=Olasupo |first4=Oluwadara Joshua |last5=Lee |first5=Sujin |last6=Luong |first6=Derek |last7=Lin |first7=Xinsong |last8=Vellore Winfred |first8=J.S. Raaj |last9=Lochner |first9=Eric |last10=Fatima |first10=Iqra |last11=Hanson |first11=Kenneth |last12=Ma |first12=Biwu |date=March 2023 |title=Efficient Red Light Emitting Diodes Based on a Zero-Dimensional Organic Antimony Halide Hybrid |journal=Advanced Materials |language=en |volume=35 |issue=9 |pages=2209417 |doi=10.1002/adma.202209417 |pmid=36524448 |bibcode=2023AdM....3509417L |s2cid=254804816 |issn=0935-9648|doi-access=free }}
List
class="wikitable"
!Name (full or part) !Formula !System !Space group !Unit cell (Å) !Volume !Density !Notes !Ref |
ammonium
|[H4N]2SbBr6 |tetragonal |I41/amd |a=10.66 c=21.52 | | |black; Sb(III) and Sb(V) |{{Cite journal |last1=Lawton |first1=Stephen L. |last2=Jacobson |first2=Robert A. |date=May 1966 |title=The Crystal Structure of Ammonium Hexabromoantimonate, (NH 4 ) 4 Sb III Sb V Br 12 |url=https://pubs.acs.org/doi/abs/10.1021/ic50039a011 |journal=Inorganic Chemistry |language=en |volume=5 |issue=5 |pages=743–749 |doi=10.1021/ic50039a011 |issn=0020-1669|url-access=subscription }} |
ammonium
|(NH4)3Sb2Br9 | | | | | |inefficient photovoltaic; soluble in ethanol |
ammonium
|(NH4)7Sb3Br16 | | | | | | |
guanidinium
|[C(NH2)3]SbBr6 | | | | | |black; Sb(V) |
guanidinium
|[C(NH2)3]3Sb2Br9 |monoclinic |C2/c |a = 15.695 b = 9.039 c = 18.364 β = 96.94° Z=4 | | |@143K; phase transition 435/450 K |{{Cite journal |last1=Terao |first1=Hiromitsu |last2=Furukawa |first2=Yoshihiro |last3=Miki |first3=Satomi |last4=Tajima |first4=Fukue |last5=Hashimoto |first5=Masao |date=2005-12-24 |title=NQR, NMR and Crystal Structure Studies of [C(NH2)3]3Sb2Br9 |url=http://link.springer.com/10.1007/s10751-005-9099-y |journal=Hyperfine Interactions |language=en |volume=159 |issue=1–4 |pages=211–216 |doi=10.1007/s10751-005-9099-y |s2cid=95437922 |issn=0304-3843|url-access=subscription }}{{Cite journal |last1=Szklarz |first1=P |last2=Zaleski |first2=J |last3=Jakubas |first3=R |last4=Bator |first4=G |last5=Medycki |first5=W |last6=Falińska |first6=K |date=2005-04-20 |title=The structure, phase transition and molecular dynamics of [C(NH 2 ) 3 ] 3 [Sb 2 Br 9 ] |url=https://iopscience.iop.org/article/10.1088/0953-8984/17/15/021 |journal=Journal of Physics: Condensed Matter |volume=17 |issue=15 |pages=2509–2528 |doi=10.1088/0953-8984/17/15/021 |bibcode=2005JPCM...17.2509S |s2cid=96818420 |issn=0953-8984|url-access=subscription }} |
Tris(N,N,N |[NH2C(N(CH3)2)2]3[Sb2Br9] |triclinic |P{{overbar|1}} |a 10.9824 b 12.1782 c 15.0405 α 71.064° β 88.199° γ 85.024° | | | |
methylammonium
|(CH3NH3)3SbBr6 |monoclinic |P21/c |a=13.577 b=8.254 c=21.665 β=134.05° Z=4 | | | |
methylammonium bromoantimonate(III)
|(CH3NH3)3Sb2Br9 | |P{{overbar|3}}m1 |a=8.188 c=9.927 Z=1 | |3.049 |yellow |{{Cite journal |last1=Varma |first1=Vijay |last2=Bhattacharjee |first2=Ramendu |last3=Vasan |first3=H.N. |last4=Rao |first4=C.N.R. |date=November 1992 |title=Infrared and Raman spectroscopic investigations of methylammonium haloantimonates(III), [N(CH3)4−nHn]3 Sb2X9 (n = 0–3, X = Cl or Br), through their phase transitions |url=https://linkinghub.elsevier.com/retrieve/pii/058485399280237Q |journal=Spectrochimica Acta Part A: Molecular Spectroscopy |language=en |volume=48 |issue=11–12 |pages=1631–1646 |doi=10.1016/0584-8539(92)80237-Q|bibcode=1992AcSpA..48.1631V |url-access=subscription }}{{Cite journal |last1=Ishihara |first1=Hideta |last2=Watanabe |first2=Koichi |last3=Iwata |first3=Ayako |last4=Yamada |first4=Koji |last5=Kinoshita |first5=Yoshihiro |last6=Okuda |first6=Tsutomu |last7=Krishnan |first7=V. G. |last8=Dou |first8=Shi-qi |last9=Weiss |first9=Alarich |date=1992-02-01 |title=NQR and X-ray Studies of [N(CH 3 ) 4 ] 3 M 2 X 9 and (CH 3 NH 3 ) 3 M 2 X 9 (M = Sb,Bi; X = Cl,Br) |journal=Zeitschrift für Naturforschung A |language=en |volume=47 |issue=1–2 |pages=65–74 |doi=10.1515/zna-1992-1-213 |s2cid=51832125 |issn=1865-7109|doi-access=free }} |
dimethyl ammonium
|[(CH3)2NH2]3SbBr6 | | | | | | |
tris (dimethylammonium) nonabromodiantimonate(III)
|[(CH3)2NH2]3Sb2Br9 |monoclinic |P21/a |a = 14.612 b = 9.228 c = 10.005 β = 94.91° Z = 2 | | | |
|[NH2(CH3)2]3Sb2Br9
| | | | | | | |
tris(Trimethylammonium) nonabromodiantimonate(III)
|[(CH3)3NH]3Sb2Br9 |orthorhomic | |a 11.40 b 10.31 c 12.91 | | | |
tetramethylammonium
|[NMe4]3[Sb2Br9] |hexagonal |P63/mmc |a=9.499 c=22.225 Z=2 | | |crimson red |{{Cite journal |last1=Hall |first1=Michael |last2=Nunn |first2=Michael |last3=Begley |first3=Michael J. |last4=Sowerby |first4=D. Bryan |date=1986 |title=Nonahalogenodiantimon(III)ates; their preparation and the crystal structures of [Hpy]3[Sb2Cl9], [NMe4]3[Sb2Br9], and [NMe4]3[Sb2Br3Cl6] |url=http://xlink.rsc.org/?DOI=dt9860001231 |journal=Journal of the Chemical Society, Dalton Transactions |language=en |issue=6 |pages=1231–1238 |doi=10.1039/dt9860001231 |issn=0300-9246|url-access=subscription }}{{Cite journal |last=Petzold |first=Walter |date=1933-11-10 |title=Komplexe Bromoverbindungen des Antimons |url=https://onlinelibrary.wiley.com/doi/10.1002/zaac.19332150111 |journal= Zeitschrift für anorganische und allgemeine Chemie|language=de |volume=215 |issue=1 |pages=92–102 |doi=10.1002/zaac.19332150111 |issn=0863-1786|url-access=subscription }} |
tetramethylammonium
|[NMe4]3[Sb2Br9]•Br2 |hexagonal |P63/mmc |a=9.585 c=22.667 Z=2 | | | |
tetramethylammonium
|[(CH3)4N]3Sb3Br9•Br2 |hexagonal |P63/mmc |a=9.5850 c=22.667 Z=2 | |2.48 |red; yellow-orange when cold |
tetramethylammonium
|[(CH3)4N]3Sb2Br9•I2 |triclinic |P{{overbar|1}} |a=9.4869 b=9.5409 c=22.4906 α=92.058° β=90.933° γ=118.386° Z=2 |1788.5 | |dark |
ethylammonium
|(C2H5NH3)2[SbBr5] |orthorhombic |Cmca |a= 7.815 b=22.301 c=18.100 Z=8 |3154.5 |2.584 |at 298K; yellow; phase transition at 158.5K; decompose >450K |
ethylammonium
|(C2H5NH3)2[SbBr5] |orthorhombic |Pbca |a=7.684 b=22.413 c=17.780 Z=8 |3062.1 |2.661 |at 90K; yellow |
ethylammonium
|(C2H5NH3)2[SbBr7] | | | | | | |
diethylammonium
|([C2H5]2NH2)3SbBr6 |hexagonal |R3c |a=15.155 c=20.085 Z=6 | | |dissolves in acetone |{{Cite journal |last1=Okuda |first1=Tsutomu |last2=Hiura |first2=Morio |last3=Koshimizu |first3=Etsuo |last4=Ishihara |first4=Hideta |last5=Kushi |first5=Yoshihiko |last6=Negita |first6=Hisao |title=The NQR and Structure of Hexabromoantimonate(III) and Bismuthate(III) Ions |date=1982-09-05 |url=http://www.journal.csj.jp/doi/10.1246/cl.1982.1321 |journal=Chemistry Letters |language=en |volume=11 |issue=9 |pages=1321–1324 |doi=10.1246/cl.1982.1321 |issn=0366-7022|url-access=subscription }} |
tetraethylammonium
|[(C2H5)4N]2SbBr6 | | | | | |very dark reddish brown |
tetraethylammonium
|[(C2H5)4N]3Sb2Br9 |hexagonal |P6322 |a=10.3 c=24.4 Z=2 |2242 |2.02 |yellow |{{Cite journal |last1=Miniewicz |first1=A. |last2=Jakubas |first2=R. |last3=Zaleski |first3=J. |date=June 1991 |title=Measurements of pyroelectric properties in [(C 2 H 5 ) 4 N] 3 Sb 2 Br 9 |url=http://www.tandfonline.com/doi/abs/10.1080/00150199108014740 |journal=Ferroelectrics |language=en |volume=118 |issue=1 |pages=23–28 |doi=10.1080/00150199108014740 |bibcode=1991Fer...118...23M |issn=0015-0193|url-access=subscription }}{{Cite journal |last1=Zaleski |first1=J. |last2=Jakubas |first2=R. |last3=Galewski |first3=Z. |last4=Sobczyk |first4=L. |date=1989-11-01 |title=Structural Phase Transitions in [(C 2 H 5 ) 4 N] 3 Sb 2 Br 9 and [(C 2 H 5 ) 4 N] 3 Bi 2 Br 9 |journal=Zeitschrift für Naturforschung A |language=en |volume=44 |issue=11 |pages=1102–1106 |doi=10.1515/zna-1989-1110 |bibcode=1989ZNatA..44.1102Z |s2cid=101200132 |issn=1865-7109|doi-access=free }} |
tetraethylammonium hexabromoantimonate(V)
|[(C2H5)4N]SbBr6 |tetragonal |I41md |a=8.7008 c=24.797 Z=4 |1877.3 |2.59 |dark red-brown |{{Cite journal |last1=Clark |first1=Robin J. H. |last2=Duarte |first2=Maria Lenor |date=1977 |title=Raman, resonance-Raman, and electronic spectra of tetraethylammonium hexabromoantimonate(V) and of tetra-n-butylammonium hexa-bromoantimonate(V) |url=http://xlink.rsc.org/?DOI=dt9770000790 |journal=Journal of the Chemical Society, Dalton Transactions |language=en |issue=8 |pages=790–793 |doi=10.1039/dt9770000790 |issn=0300-9246|url-access=subscription }}{{Cite journal |last1=Jacobson |first1=Robert A. |last2=Hackert |first2=Marvin L. |last3=Keiderling |first3=Timothy A. |date=May 1971 |title=Crystal structure of tetraethylammonium hexabromoantimonate(V), (C2H5)4NSbBr6 |url=https://pubs.acs.org/doi/abs/10.1021/ic50099a044 |journal=Inorganic Chemistry |language=en |volume=10 |issue=5 |pages=1075–1078 |doi=10.1021/ic50099a044 |issn=0020-1669|url-access=subscription }} |
n-propylammonium
|(n-C3H7NH3)2SbBr5 |orthorhombic |? |a =7.884 b=14.516 c=15.913 Z=4 |1821.1 |2.33 |4 phase transitions: 189K, 165/163, 137/154 |{{Cite journal |last1=N. |first1=Pislewski |last2=J. |first2=Tritt-Goc |last3=R. |first3=Jakubas |title=Study on phase transitions and dynamics of n-propyl amine groups in (n-C3H7NH3)2SbBr5 |url=https://inis.iaea.org/search/search.aspx?orig_q=RN:29023450 |language=Polish}}{{Cite journal |last1=Jakubas |first1=R. |last2=Bator |first2=G. |last3=Foulon |first3=M. |last4=Lefebvre |first4=J. |last5=Matuszewski |first5=J. |date=1993-03-01 |title=Structural Phase Transitions in (n-C 3 H 7 NH 3 ) 2 SbBr 5 |journal=Zeitschrift für Naturforschung A |language=en |volume=48 |issue=3 |pages=529–534 |doi=10.1515/zna-1993-0314 |bibcode=1993ZNatA..48..529J |s2cid=102140570 |issn=1865-7109|doi-access=free }} |
di-n-propylammonium
|[(n-C3H7)2NH2]3SbBr6 |hexagonal |R{{overbar|3}}c |a=13.649 c=31.548 Z=6 | | |dissolves in acetone |
tris(Tri-n-propylammonium) nonabromodiantimonate(III)
|[(n-C3H7)3NH]3Sb2Br9 |orthorhombic |? |a 12.91 b 14.51 c 20.0 | | | |
bis(Isopropylammonium) pentabromoantimonate(III)
|[(i-C3H7)2NH2]2SbBr5 |orthorhombic | |a 14.99 b 16.687 c 21.72 | | | |
tetrapropylammonium
|[(C3H7)4N][SbBr4] |orthorhombic |Pbca |a=15.566 b=13.822 c=19.574 Z=8 |4211.5 | |yellow |
isopropylammonium
|[(CH3)2CHNH3]2SbBr5 |orthorhombic | |a=12.013 b =12.134 c=12.525 | | |phase transition at 171K, 180 K |
isopropylammonium
|[(CH3)2CHNH3]2SbBr5 |monoclinic | | | | | |
tris(N-ethyl-N,N-dipropylpropan-1-aminium) tetrakis(μ-bromo)-octabromo-tri-antimony
|(Et(n-Pr)3N)3[Sb3Br12] |triclinic |P{{overbar|1}} |a 10.6469 b 14.8847 c 18.3714 α 86.082° β 85.502° γ 84.116° | | | |
isobutyl
|(i-C4H9NH3)2SbBr5 | | | | | | |
ethanediammonium
|[NH3(CH2)2NH3]5(Sb2Br11)2·4H2O |monoclinic |P21/a |a = 14.346 b = 13.206 c = 17.027 β = 113.05° Z = 2 | |2.941 | |
N,N,N |(C6H18N2)2[Sb2Br10]·H2O |orthorhombic |Pbca |a = 18.0860 b = 19.1755 c = 19.4619 Z=8 |6749.5 |2.553 |yellow |
anilinium
|(C6H5NH3)2SbBr5 |orthorhombic |Pbca |a = 19.704 b = 7.914 c = 25.556, Z = 8 |3985 |2.365 |yellow green; insoluble water |
dihydrazinium pentabromoantimonite
|(N2H5)2SbBr5 | | | | | |yellow |
Trihydrazinium nonabromodiantimonite
|(N2H5)3Sb2Br9 | | | | | |yellow |
Undecahydrazinium heptadecabromodiantimonite
|(N2H5)11Sb2Br17 | | | | | |yellow; melt 165° |
Decahydrazinium nonadecabromotriantimonite
|(N2H5)10Sb3Br19 | | | | | |yellow |
triazolinium
|(C2H4N3)2[SbBr5]·(C2H4N3)Br |orthorhombic |P212121 |a=8.6087 b=11.7985 c=20.5457 | | | |
1,2,4-triazolium
|(C2N3H4)3[SbBr6] |tetragonal |P42/m |a=11.149 c=8.318 Z=2 |1033.9 |2.606 |@320K |
1,2,4-triazolium
|(C2N3H4)3[SbBr6] |monoclinic | |a=15.699 b=16.294 c=15.018 β = 90.41 Z=8 |4097 |2.631 |@293K | |
allylammonium
|(C3H5NH3)3SbBr6 |monoclinic |C2/m | | | |4 phases |
butylammonium
|[n-C4H9NH3]2•[SbBr5] |orthorhombic |Pnma |a=16.845 b=54.899 c=15.697 | | |340K deep yellow; 3 phases |
butylammonium
|[n-C4H9NH3]2•[SbBr5] |monoclinic |P2/m |a=15.597, b=62.854, c=16.771 β=92.05° | | |300K |
tris(n-Butylammonium) hexabromo-antimony(III)
|[n-C4H9NH3]3•[SbBr6] | | |a 11.47 b 15.07 c 18.57 | | | |
di-n-butylammonium
|[(n-C4H9)2NH2]3•[SbBr6] |monoclinic |P21/c |a 13.03 b 13.51 c 18.94 β 94.0° | | | |
tetra-n-butylammonium hexa-bromoantimonate(V)
|[(n-C4H9)4N]•[SbBr6] | | | | | | |
pentylammonium
|[n-C5H11NH3]2•[SbBr5] |orthorhombic |Pna21 |a=17.0105 b=32.875 c=7.8882 | | |298K; 3 phases transitions at 388K 224K |
pentylammonium
|[n-C5H11NH3]2•[SbBr5] |orthorhombic |P212121 |a=16.9234 b=32.3689 c=7.7418 | | |86K |
2,2-difluoroethylammonium
|[C2H6F2N]3SbBr6 |monoclinic |P121/n1 |a=8.0145 b=12.1192 c=21.2967 β=91.686 Z=4 |2067.6 |2.722 |yellow |
N-ethyl-1,3-propanediammonium
|[C5N2H16]2SbBr5 |monoclinic |P21/c |a=21.426 b=7.889 c=19.96 β=116.79° Z=8 |3012 | | |
N-ethyl-1,3-propanediammonium
|[C5N2H16]2SbBr5 |orthorhombic |Pnma |a=19.23 b=7.894 c=10.118 Z=4 |1536 | |yellow |
bis(N,N-diethylethylendiammonium) decabromodiantimoinate(III)
|[C6H18N2]2Sb2Br10 |monoclinic |P21/c |a = 10.7309 b = 10.5842 c = 14.5551 β = 96.962° Z = 4. | | |yellow |
1,5-pentanediammonium pentabromoantimonate (III)
|[NH3(CH2)5NH3]SbBr5 |orthorhombic |P212121 |a 7.964 b 13.9424 c 14.065 | | |@293K |
1,5-pentanediammonium pentabromoantimonate (III)
|[NH3(CH2)5NH3]SbBr5 |orthorhombic |Pnma |a 14.04 b 8.04 c 13.97 | | |@393K |
Ethyldimethylphenylammonium
|[EtMe2PhN]3[Sb2Br9] |orthorhombic |Pnma |a = 35.620 b = 9.954 c = 12.761 Z = 4 | | | |
Tris(N,N-dimethylanilinium) tri--bromido-bis[tribromidoantimonate(III)]
|(C8H12N)3[Sb2Br9] |triclinic |P{{overbar|1}} |a 9.7857(b 13.7658(c 17.0297(α 66.581( β 78.689( γ 72.601( Z=2 | | | |
|[CH3SC(NH2)2]2SbBr5
| | |11.4258 b=8.9079 c=17.3627 β=92.225 Z=4 |1765.8 |2.647 | |
cyclopropylammonium
|[C3H8N]2SbBr5 |monoclinic |P21/c |a=11.8937 b=19.0986 c=7.8047 β = 108.908° |1168.0 |2.525 |270K |
cyclopropylammonium
|[C3H8N]2SbBr5 |orthorhombic |Pnca |a=22.5314 b=18.9885 c=7.8845 Z=8 |2336.0 |2.511 |300K |
cyclopropylammonium
|[C3H8N]2SbBr5 |orthorhombic |Bbcm |a=22.4485 b=18.9653 c=7.9488 Z=8 |2256 |2.503 |325K; band gap 2.41 eV; phase changes at 290 K and = 315 K |
Benzeneethanammonium
|(C8NH12)2SbBr5 | | | | | |yellow |
phenylmethylammonium
|(C6H5CH2NH3)3SbBr6 |monoclinic |P21/c |a 15.2246 b 8.0632 c 24.3042 β 100.005° Z=4 |2938.2 |2.093 |yellow |
(R)-(−)-1-cyclohexylethylammonium
|(R-CHEAH)Sb3Br10 |monoclinic |P21 |a=12.76938 b=30.1777 c=13.2336 β=90.818 | | | |
Pyrrolidinium
|[C4H9N]2SbBr8 |monoclinic | |a=31.4 b=9.71 c=15.0 β=99.0° Z=8 |4517 |2.50 |black |
2-Pyrolidonium
|[C4H6ONH]2SbBr8 | | | | | |black; orange red when cold |
N-methylpyrrolidinium
|[C4H9NCH3]3Sb2Br9 |trigonal |R3c |a=15.6943 c=15.6943 Z=6 |5018.8 |2.424 |yellow @293K |
N-methylpyrrolidinium
|[C4H9NCH3]3Sb2Br9 |trigonal |R{{overbar|3}}c |a=15.9951 c=23.1124 Z=5 |5120.9 |2.376 |@335K |
N-methylpiperidine
|(C6H14N)3Sb3Br12 |monoclinic |P21/n |a=10.9372 b=21.928 c=17.598 β=90.796° Z=4 |4219.5 | | |
Piperidinium
|[C5H11N]2SbBr8 |monoclinic | |a=28.8 b=19.8 c=18.7 β=116.28 Z=16 |9561 |2.58 |black |
Piperazine-1,4-diium
|(C4H12N2)[SbBr5]·H2O |monoclinic |P21/n |a=9.9162 b=14.4090 c=10.3898 β=99.432 Z=4 |1464.45 |2.846 | |
Morpholinium
|[NH2(C2H4)2O]SbBr4 |orthorhombic |Pbca |a=12.273 b=8.397 c=23.276 Z=8 |2399 |2.933 |yellow |
Morpholinium
|[NH2(C2H4)2O]2[SbBr5] |orthorhombic |P212121 |a 9.274 b 10.325 c 18.472 Z=4 |1768.8 |2.620 |yellow; piezoelectric |
Morpholinium
|[C4H9ONH]2SbBr8 |orthorhombic |Pna21 |a=28.01 b=8.31 c=10.02 Z=4 |2332 |2.64 |black; red when cold |
Pyridinium
|(C5H5NH)SbBr4 |triclinic |P{{overbar|1}} | | | |@116K |
Pyridinium
|(C5H5NH)SbBr4 |monoclinic |C2/c |a=11.825 b=13.048 c=7.798 β=93.87° Z=4 | |2.922 |@297K |
Pyridinium
|(C5H5NH)6SbIIISbV3Br24 |orthorhombic |CmC21 |a=17.51 b=23.77 c=16.46 Z=4 |6851 |2.80 |black |
benzylammonium
|(C6H5CH2NH3)2SbBr5 |monoclinic |P21/a |a=8.0254 b=19.5087 c=14.5079 β=107.451 Z=4 |2166.89 |2.261 |yellow |
1-methylpyridinium
|(1−CH3C5H4NH)SbBr4 |monoclinic |P21/c |a=12.73 b=13.54 c=7.59 β=107.3 Z=4 |1250 |2.85 |pale yellow |
bis(1-methylpyridin-1-ium) hexabromo-antimony tribromide
|(1−CH3C5H4NH)2SbBr6•Br3 |triclinic |P{{overbar|1}} |a 7.4567 b 9.4488 c 9.6777 α 68.629° β 89.848° γ 73.002° |1029.2 | | |
2-methylpyridinium
|(2−CH3C5H4NH)SbBr4 |monoclinic |P21/c |a=12.84 b=13.31 c=7.65 β=106.6 Z=4 |1252 |2.84 |pale yellow |
3-methylpyridinium
|(3−CH3C5H4NH)SbBr4 |monoclinic |P21/c |a=12.51 b=13.64 c=7.72 β=106.9 Z=4 |1260 |2.76 |pale yellow |
bis(2-bromo-5-methylpyridinium) hexabromoantimonate tribromide
|(2-Br-5-MePy)2[SbBr6](Br3) |monoclinic |Im |a 8.4041 b 13.341 c 12.237 β 95.731° | | | |
3-carboxylpyridinium
|(3−COOHC5H4NH)2SbBr5 |monoclinic |C2/c |a=14.10 b=19.43 c=8.01 β=98.6° Z=4 |2169 |2.36 |lemon yellow |
4-methylpyridinium
|(4−CH3C5H4NH)SbBr4 |monoclinic |P21/c |a 12.011 b 13.581 c 7.7637 β 90.341° | | | |
4-methylpyridinium
|(4−CH3C5H4NH)2SbBr5 |triclinic |P{{overbar|1}} |a=10.66 b=10.86 c=9.30 α=108.8° β=97.7° γ=99.2° Z=2 |985 |2.39 |yellow needles |{{Cite journal |last1=Ishihara |first1=Hideta |last2=Dou |first2=Shi-qi |last3=Weiss |first3=Alarich |date=March 1994 |title=NQR and X-Ray Study of Bis(4-methylpyridinium) Pentabromoantimonate(III), (4-CH 3 C 5 H 4 NH) 2 SbBr 5 |url=http://www.journal.csj.jp/doi/10.1246/bcsj.67.637 |journal=Bulletin of the Chemical Society of Japan |language=en |volume=67 |issue=3 |pages=637–640 |doi=10.1246/bcsj.67.637 |issn=0009-2673|url-access=subscription }} |
4-methylpyridinium
|(4−CH3C5H4NH)3Sb2Br9•I2 |monoclinic |P21 |a=8.3290 b=23.5510 c=9.4722 β=104.388 Z=2 |1799.7 | | |
4-methylpyridinium
|(4−CH3C5H4NH)2SbBr5•I2 |monoclinic |P21/n |a=7.5955 b=14.6757 c=9.5902 β=91.607 Z=2 |2182.85 | | |
4-methylpyridinium
|(4-C6H7NH)2SbVBr9 |monoclinic |C2/m |a=18.39 b=7.440 c=9.84 β=113.14° | |2.760 |red |
α-picolinium
|(2−CH3C5H4NH)2SbBr9 |triclinic |P{{overbar|1}} |a 9.249 b 9.750 c 7.645 α 90.07° β 107.46° γ 70.52° Z=2 | |2.77 |black; orange at −174° |{{Cite journal |last1=Lawton |first1=Stephen L. |last2=Jacobson |first2=Robert A. |date=October 1968 |title=Crystal structure of di-.alpha.-picolinium nonabromoantimonate(V) |url=https://pubs.acs.org/doi/abs/10.1021/ic50068a036 |journal=Inorganic Chemistry |language=en |volume=7 |issue=10 |pages=2124–2134 |doi=10.1021/ic50068a036 |issn=0020-1669|url-access=subscription }} |
β-picolinium
|(3−CH3C5H4NH)2SbBr9 |monoclinic | |Z=2 | |2.74 |black; orange at −174° |
γ-picolinium
|(4−CH3C5H4NH)2SbBr9 |monoclinic | |Z=2 | |2.77 |black; red at −174° |
1-fluoropyridinium
|(1-FPy)3[Sb2Br9] |monoclinic |C2/c |a=21.85 b=21.15 c=13.85 β=104.6° Z=8 |6179 |2.70 |deep yellow |
1-bromopyridinium
|? |monoclinic |C2/c |a=11.83 b=13.03 c=7.70 β=93.9° |1183 |2.4 |light orange |
2-chloropyridinium
|(2-ClPyH)2SbBr5 |monoclinic |P21/a |a=10.64 b=15.87 c=5.88 β=105.3° Z=2 |957 |2.60 |orange |
2-chloropyridinium
|(2-ClPyH)SbBr6 |monoclinic |P21/c |a=13.0770 b=7.3498 c=16.5301 β=112.117° | | |Sb(V) |
2-bromopyridinium
|(2-BrPyH)2SbBr5 |monoclinic |P21/a |a=10.53 b=16.17 c=5.89 β=104.8° Z=2 |989 |2.82 |red |
2-bromopyridinium
|(2-BrPyH)SbBr6 |monoclinic |P21/c |a=13.111 b=7.3787 c=16.555 β=111.179° | | |Sb(V) |
bis(2-iodopyridinium) hexabromoantimonate tribromide
|(2-IPyH)2[SbBr6](Br3) |monoclinic |P21/n |a 8.1800 b 12.9394 c 12.5865 β 105.412° | | | |
3-chloropyridinium
|(3-ClPyH)SbBr6 |orthorhombic |Pca21 |a=16.6414 b=7.3471 c=24.2543 Z=8 |2965.5 | |cherry-red |
3-bromopyridinium
|(3-BrPyH)2SbBr5 |monoclinic |P21/c |a=18.37 b=11.98 c=9.35 β=102.5° Z=4 |2009 |2.77 |pale yellow |
3-bromopyridinium
|(3-BrPyH)SbBr6 |orthorhombic |Pca21 | | | |cherry-red |
3-iodopyridinium
|(3-IPyH)2SbBr5 |monoclinic |P21/c |a=17.99 b=12.31 c=9.35 β=91.5° Z=4 |2070 |2.99 |pale yellow |
4-bromopyridinium pentabromoantimonate(III)
|(4-BrC5H4NH)2SbBr5 |triclinic |P{{overbar|1}} |a = 9.186 b = 10.622 c = 10.703 α = 99.665° β = 97.393° γ = 108.539° Z = 2 | | | |
bis(4-bromopyridinium) hexabromoantimonate tribromide
|(4-BrPyH)2[SbBr6](Br3) |monoclinic |P21/c |a 7.3255 b 20.667 c 16.5665 β 95.627° | | | |
2,6-dichloropyridinium
|(2,6-ClPyH)[SbBr4] |monoclinic |P2/m |a=10.45 b=10.76 c=13.45 β=110.2 Z=4 |1491 |2.76 |pale yellow |
2,6-dibromopyridinium
|(2,6-BrPyH)3[SbBr6](Br3) · 2H2O |monoclinic |C2/c |a=32.8242 b=9.6155 c=14.7877 β=101.732° | | | |
3,5-dichloropyridinium
|(3,5-ClPyH)2[SbBr5] |orthorhombic |Pbca |a=21,77 b=8.14 c=24.38 Z=8 |4320 |2.52 |deep yellow |
N-ethylpyridinium
|EtPySbBr6 | | | | | | |
N-propylpyridinium
|1-n-PrPySbBr6 |monoclinic |P21/n |a=7.3687 b=16.4706 c=13.8620 β=97.054 Z=4 |1669.65 | | |
N-butylpyridinium
|1-n=BuPySbBr6 |orthorhombic |P212121 |a=7.4277 b=14.1293 c=16.7699 Z=4 |1760.0 | | |
2-aminopyridinium
|[2-NH2C5H4NH][SbBr4] |monoclinic |P21/c |a 12.484 b 13.106 c 7.492 β 105.84° Z=4 |1179.1 |3.022 |@100K phase transition at 396/412K |
4-aminopyridinium
|(4-NH2C5H4NH)SbBr4 |monoclinic |P21/c |a 11.548 b 14.029 c 7.432 β 93.19° | | |@220K |
tetrakis(2,2'-bipyridin-1-ium) tetrakis(μ-bromo)-hexadecabromo-tetra-antimony
|(2,2′-bipyH)4[Sb4Br20] |monoclinic |P21/c |a 14.5026 b 14.6945 c 16.5497 β 109.991° | | | |
bis(pyridinium)ethane
|(PyC2){[SbBr6](Br3)} |triclinic |P{{overbar|1}} |a=7.3269 b=9.1941 c=9.7994 α=64.474 β=80.207 γ=86.244 Z=1 |586.99 | |cherry-red |
1,1′-(1,2-ethanediyl)bis(pyridine)
|PyC22+SbBr5 |triclinic |P{{overbar|1}} |a 10.1060 b 10.2956 c 11.1394 α 105.030° β 101.709° γ 117.233° | | | |
1,1′-(1,2-ethanediyl)bis(3,5-dimethylpyridine)
|3,5-MePyC22+SbBr5 |monoclinic |P2/n |a 6.2898 b 8.7454 c 20.408 β 90.438° | | | |
1,1′-(1,2-ethanediyl)bis(pyridine)
|(C2Py)2[Sb2Br10] |triclinic |P{{overbar|1}} |a 6.1343 b 9.2857 c 17.2041 α 90.331° β 100.259° γ 99.912° | | | |
1,1′-(1,2-ethanediyl)bis(pyridine)
|(C2Py)2[Sb2Br10] |monoclinic |C2/c |a 19.6880 b 10.0152 c 20.8410 β 111.104° | | | |
1,1′-(1,2-ethanediyl)bis(3,5-dimethylpyridine)
|(3,5-MePy){[SbBr4]} |monoclinic |P21/n |a 20.5536 b 7.2974 c 21.2510 β 117.694° | | | |
bis(pyridinium)propane
|(PyC3)2[Sb2Br9][SbBr6] |orthorhombic |Pmmm |a=20.3785 b=15.5018 c=7.4618 Z=2 |2357.2 | |mixed III V valence |
bis(pyridinium)butane
|(PyC4){[SbBr6](Br3)} |triclinic |P{{overbar|1}} |a=7.8627 b=9.1285 c=10.1514 α=68.392° β=89.669° γ=72.048° Z=1 |639.63 | | |
4-ethylpyridinium
|(4−CH3CH2C5H4NH)3Sb2Br14 |orthorhombic |Pna21 |Z=4 | |2.55 |black; orange-red at −174° |
1,1′-(propane-1,3-diyl)bis(4-methylpyridin)-1-ium
|(4-MePyC3)2[SbBr6]2[Br5]2 |monoclinic |P21/n |a=7.7157 b=16.1786 c=24.292 β=96.972° | | |Sb(V) |
propanediyl-bis(3-methylpyridinium)
|(3-MePyC3)3[Sb4Br16] |monoclinic |P21/n |a 11.6777 b 42.282 c 16.5504 β 95.618° | | | |
1,1'-(ethane-1,2-diyl)bis(3-methylpyridin-1-ium)
|(3-MePyC2)3[Sb2Br9]2 |triclinic |P{{overbar|1}} |a 10.6368 b 10.8059 c 15.4810 α 76.034° β 81.735° γ 83.387° | | | |
bis(1,1'-(butane-1,4-diyl)bis(3-methylpyridin-1-ium)) hexakis(μ-bromo)-decabromo-tetra-antimony(iii)
|(3-MePyC4)3[Sb4Br16] |monoclinic |P21/n |a 14.2410 b 11.2731 c 19.0662 β 110.674° | | | |
4,4'-dimethyl-1,1'-butanediylbis(pyridinium)
|(4-MePyC4)[Sb2Br8] |monoclinic |P 2/c |a 26.313 b 6.4010 c 17.9886 β 109.026° | | | |
4,4'-dimethyl-1,1'-butanediylbis(pyridinium)
|(4-MePyC4)2[Sb4Br16] |monoclinic |P21/n |a 11.4661 b 19.7236 c 12.5217 β 92.726° | | | |
1,3,4-trimethylpyridin-1-ium
|1,3,4-MePy[SbBr6] |triclinic |P{{overbar|1}} |a 8.3195 b 8.9921 c 12.3360 α 86.146° β 76.520° γ 71.872° | | |Sb(V) |
1,4-dimethylpyridin-1-ium
|1,4-MePy[SbBr6] |triclinic |P{{overbar|1}} |a 7.6803 b 8.5900 c 12.6261 α 75.226° β 88.079° γ 79.872° | | |Sb(V) |
1,2-dimethylpyridinium
|(1,2-MePy)2[SbBr6](Br3) |monoclinic |P21/n |a=7.3284 b=10.5875 c=16.7538 β=96.005° | | |Sb(V) |
1,3-dimethylpyridinium
|(1,3-MePy)2[SbBr6](Br3) |triclinic |P{{overbar|1}} |a 7.2611 b 9.086 c 11.1895 α 67.617° β 87.457° γ 72.16° | | | |
2,4-dimethylpyridinium
|? |orthorhombic |Pmmn |a=12.06 b=12.97 c=11.49 |1797 |2.2 |yellow |
2,6-dimethylpyridinium
|(2,6-MePy)3[Sb2Br9] |monoclinic |P21/c |a=12.10 b=15.56 c=21.27 β=115.7 Z=4° |3629 |2.36 |pale yellow |
1-ethyl-3-methylpyridinium
|(1-Et-3-MePy)2[SbBr6](Br3) |triclinic |P{{overbar|1}} |a 7.2472 b 9.4088 c 11.5541 α 69.263° β 81.162° γ 71.303° | | | |
4-ethyl-1-methylpyridinium
|(4-Et-1-MePy)2[SbBr6](Br3) |monoclinic |P21/n |a 8.4645 b 13.0802 c 13.1574 β 105.702° | | | |
bis(2,6-dimethylpyridin-1-ium) hexabromo-antimony pentabromide
|(2,6-MePy)2[SbBr6](Br5) |monoclinic |P21/c |a 7.4584 b 18.0860 c 21.626 β 93.607° Z=4 |2911.4 | | |
bis(1,3,5-trimethylpyridin-1-ium) hexabromo-antimony tribromide
|(1,3,5-MePy)2[SbBr6](Br3) |triclinic |P{{overbar|1}} |a 8.1964 b 8.2015 c 12.5202 α 92.883° β 103.923° γ 115.467° Z=4 |1085.3 | |100K |
2,4,6-trimethylpyridinium
|(2,4,6-MePy)3[Sb2Br9] |monoclinic |P21/n |a=10.36 b=42.36 c=9.09 β=100.2° Z=4 |3926 |2.25 |yellow-tan |
2,4,6-trimethylpyridinium
|(2,4,6-MePy)[SbBr]•0.5Br2 |monoclinic |P21/n |a 10.4938 b 13.6198 c 12.8807 β 90.339° Z=4 |1840.9 | |100k |
bis(3,5-dimethylpyridin-1-ium) hexabromo-antimony tribromide
|(3,5--MePy)2[SbBr6](Br3) |orthorhombic |Pnnm |a 17.1097 b 10.4401 c 7.3438 Z=2 |1311.8 | | |
bis(1-ethyl-3-methylpyridinium) hexabromoantimonate tribromide
|(1-Et-3-MePy)2[SbBr6](Br3) |triclinic |P{{overbar|1}} |a 7.2472 b 9.4088 c 11.5541 α 69.263° β 81.162° γ 71.303° | | | |
1-ethyl-4-methylpyridin-1-ium
|(1-Et-4-MePy)2[SbBr6](Br3) |monoclinic |P21/n |a=11.4927 b=7.3613 c=16.9266 β=100.782° | | |Sb(V) |
1-ethyl-2-methylpyridin-1-ium
|(1-Et-2-MePy)2[SbBr6](Br3) |monoclinic |P21/n |a=8.3421 b=13.196 c=13.183 β=105.40° | | |Sb(V) |
1-ethyl-2,6-dimethylpyridin-1-ium hexabromoantimonate
|(1-Et-2,6-MePy)[SbBr6] |monoclinic |P21/c |a 9.9470 b 11.5017 c 16.4632 β 107.201° | | | |
|(PyC3)3[Sb2Br9]2
| | | | | | |
|(PyC4)[Sb2Br8]
| | | | | | |
|(PyC5)2[α-Sb4Br16]
| | | | | | |
|(PyC6)2[Sb2Br10]
| | | | | | |
|(4-MePyC2)2[Sb2Br10]
| | | | | | |
|(4‑MePyC3)2[α-Sb4Br16]
| | | | | | |
|(4-MePyC5)2[α-Sb4Br16]
| | | | | | |
1-benzylpyridin-1-ium hexabromoantimonate
|C6H5CH2PySbBr6 |orthorhombic |Pnma |a=12.6594 b=17.3414 c=8.6389 Z=4 |1896.5 | | |
bis(1-benzyl-2-methylpyridinium) hexabromoantimonate tribromide
|(CH3-C6H5CH2Py)2SbBr6(Br3) |triclinic |P{{overbar|1}} |a 8.9834 b 10.2599 c 10.3601 α 94.223° β 102.737° γ 111.846° | | | |
bis(1-(4-bromobenzyl)pyridinium) hexabromoantimonate tribromide
|(BrC6H4CH2Py)2SbBr6(Br3) |monoclinic |P21/c |a 8.6483 b 15.1885 c 13.3520 β 98.887° | | | |
2,2'-bipyridinium pentabromoantimonate (III)
|(2,2'-C10H8N2H2)SbBr5 |monoclinic |P21/c |a = 14.575 b = 14.726 c = 16.775 β = 110.34° Z = 8 | | | |
4,4'-bipyridinium pentabromoantimonate (III)
|(4,4'-C10H8N2H2)SbBr5 |triclinic |P1 |a = 11.28.7 b = 10.121 c = 8.548 α = 98.94° β = 101.06° γ = 113.57° Z = 2 | | | |
imidazolium
|(C3N2H5)3SbBr6.H2O |monoclinic |P21/c |a=8.9137 b=19.2032 c=12.7984 β=90.650° | | | |
imidazolium
|(C3N2H5)5Sb2Br11 |monoclinic |P21/n |a 9.1399 b 15.150 c 13.969 β 96.19° | | |ferroelectric Curie Point 145K; 4 phases |{{Cite journal |last1=Piecha |first1=A. |last2=Pietraszko |first2=A. |last3=Bator |first3=G. |last4=Jakubas |first4=R. |date=May 2008 |title=Structural characterization and ferroelectric ordering in (C3N2H5)5Sb2Br11 |url=https://linkinghub.elsevier.com/retrieve/pii/S0022459608001047 |journal=Journal of Solid State Chemistry |language=en |volume=181 |issue=5 |pages=1155–1166 |doi=10.1016/j.jssc.2008.02.029|bibcode=2008JSSCh.181.1155P |url-access=subscription }} |
thiazolium
|(C3H4NS)6Sb4Br18·2H2O |triclinic |P{{overbar|1}} |a 11.060 b 11.465 c 12.957 α 116.21° β 100.71° γ 98.87° | | | |
quinolinium
| |monoclinic |Cc |a=15.28 b=14.04 c=7.44 β =118.3 Z=4 |1405 |2.70 |light yellow |
quinolinium
|(C9H7NH)2SbBr9 |monoclinic |P21/n |as=7.518 b=11.316 c=16.351 β =97.41 Z=2 | | |Sb(V) |
3-Bromoquinolinium
|(3-BrQuinH)4[Sb2Br10] |monoclinic |C2/c |a 15.3947 b 13.7967 c 22.8880 β 92.039° | | | |
5-Bromoquinolinium
|(5-BrQuinH)2[SbBr5] |monoclinic |C2/c |a 23.8681 b 12.2567 c 8.6474 β 106.128° | | | |
3-Bromo-1-methylquinolinium
|(1-Me-3-BrQuin)3[Sb3Br12] |triclinic |P{{overbar|1}} |a 9.8582 b 11.7183 c 21.6576, α 98.981° β 96.402° γ 92.371° | | | |
isoquinolinium
|isoquinHSbBr4 |monoclinic |P21/a |a=13.11 b=14.14 c=7.57 β=91.4 Z=4 |1403 |2.71 |light tan |
N-methyl quinolinium
|(N-MeQuin)2{[SbBr6](Br3)} |triclinic |P{{overbar|1}} |a=8.0902 b=8.5656 c=11.6475 𝛼 = 68.901° β = 79.204° 𝛾 = 77.120° Z=1 |728.98 | | |
N-methyl isoquinolinium
|(N-MeIsoquin)2{[SbBr6](Br3)} |monoclinic |P21/c |a=12.9656 b=9.3423 c=12.5920 β = 107.233° Z=2 |1456.8 | | |
N-ethyl quinolinium
|(N-EtQuin)[SbBr6] |orthorhombic |Pnma |a=14.5122 b=11.4005 c=11.2135° Z=4 |1855.2 | | |
tris(6-methylquinolinium) hexabromoantimonate(III)
|(6-MeQuin)3[SbBr6] | | | | | | |
2-methyl-1,3-benzoxazole
|SbBr5(boxH)2 |triclinic |P{{overbar|1}} |a=8.560 b=11.008 c=12.751 α=102.836° β=106.173° γ=93.398° | | | |
quinuclidinium
|(C9H7NH)2SbVBr9 |monoclinic |P21/n |a=7.518 b=11.316 c=16.351 β=97.41° Z=2 | |2.67 |red |
quinuclidinium
|(C7H13NH)4SbIIISbVBr12.2Br2 |cubic |Fm3m |a=13.873 |2670 |2.45 |black |
3-ammoniumpropyl imidazolium pentabromoantimonate (III)
|[C6H13N3]2+[SbBr5]2− |orthorhombic |P212121 |8.7120 b = 12.6608 c = 14.3498 Z = 4 | | | |
trihydroxonium enneabromidodiantimonate(III)
|(H3O)3Sb2Br9 |monoclinic |P21/n |a = 13.4679 b = 7.6319 c = 19.1397 β = 90.240° Z=4 |1967.3 |3.443 |yellow |
hexabromoantimonic(V) acid trihydrate
|HSbBr6 · 3H2O |monoclinic |P21/c |a = 7.110 b = 13.532 c = 12.846 β = 94.87 Z=4 | | |melt 330K |
tetramethylphosphonium
|[(CH3)4P]3[Sb2Br9] |hexagonal |P31/c |a 9.7931 c 22.697 | | |deep yellow |
trimethylphosphonium
|[(CH3)3PH][SbBr4] |monoclinic |P21/c |a=10.9103 b=19.8342 c=11.3617 β=100.744 Z=4 |2415.54 |2.851 |colourless |
Methyltriphenylphosphonium
|(MTP)6SbBr6Sb2Br9⋅H2O |trigonal |R3 |a=19.7793 c=27.2770 Z=3 |9241 |1.749 | |
Methyltriphenylphosphonium
|(MTP)2SbBr5 |monoclinic |P21/c |a=12.7399 b=12.3833 c=26.0206 β=96.373 Z=4 |4079.7 |1.752 | |
tetraphenylphosphonium
|P(C6H5)4SbBr6 |monoclinic |C2/c |a = 16.887 b = 7.357 c = 23.367 β = 93.98° Z=4 |2896.1 | |yellow |
triphenyl(9-phenyl-9H-carbazol-3-yl) phosphonium antimony bromide
|TPPcarzSbBr4 |triclinic |P{{overbar|1}} |a=9.77183 b=11.42472 16.15939 α=88.2199° β=80.7810° γ=71.8474°, Z = 2 |1691.77 |1.857 |red LED |
Tetraphenylphosphonium Ikosioctabromooctaantimonate(III)
|(PPh4)4Sb8Br28 |triclinic |P{{overbar|1}} |a=12.491 b=13.078 c=21.523 α=102.93° β=100.83° γ= 100.42°, Z = 2 |3273 |2.318 | |
Tris-Chlorobromophosphazeno-carbenium
|[C(NP(Br0,78Cl0,22)3)3]SbBr6 |orthorhombic |Pbca |a = 27.92 b = 11.23 c = 17.54 Z = 8 | | | |
|Rb3Sb2Br9
|monoclinic |P21/n | | | | |{{Cite journal |last=Wheeler |first=H. L. |date=1893-10-01 |title=On the double halides of antimony with rubidium |url=https://ajs.scholasticahq.com/article/62893 |journal=American Journal of Science |language=en |volume=s3-46 |issue=274 |pages=269–279 |doi=10.2475/ajs.s3-46.274.269 |bibcode=1893AmJS...46..269W |s2cid=130685803 |issn=0002-9599}}{{Cite book |last1=Brik |first1=Mikhail G. |url=https://books.google.com/books?id=bEKwEAAAQBAJ&pg=PA102 |title=Luminescent Materials: Fundamentals and Applications |last2=Srivastava |first2=Alok M. |date=2023-03-06 |publisher=Walter de Gruyter GmbH & Co KG |isbn=978-3-11-060787-1 |pages=102 |language=en}} |
|Rb4Sb2Br12
|tetragonal |I41/amd |a = 10.70 and c = 21.69 Z=8 | |4.17 |black |{{Cite journal |last1=Ephraim |first1=Fritz |last2=Weinberg |first2=S. |date=November 1909 |title=Doppelhalogenide des drei-, vier- und fünfwertigen Antimons |url=https://onlinelibrary.wiley.com/doi/10.1002/cber.19090420441 |journal=Berichte der Deutschen Chemischen Gesellschaft |language=en |volume=42 |issue=4 |pages=4447–4456 |doi=10.1002/cber.19090420441 |issn=0365-9496}}{{Cite journal |last1=Hubbard |first1=Camden |last2=Jacobson |first2=Robert |date=1968-01-01 |title=The Crystal Structure of Rb4SbIIISbvBr12 |url=https://scholarworks.uni.edu/pias/vol75/iss1/16 |journal=Proceedings of the Iowa Academy of Science |volume=75 |issue=1 |pages=85–96 |issn=0085-2236}} |
|Rb7Sb3Br16
|orthorhombic |Cmcm |a = 23.4716 b = 13.57.89 c = 35.3947 | | |yellow |{{Cite journal |last1=Chang |first1=Jen-Hui |last2=Doert |first2=Thomas |last3=Ruck |first3=Michael |date=2020-09-25 |title=The crystal structures of α -Rb 7 Sb 3 Br 16 , α - and β -Tl 7 Bi 3 Br 16 and their relationship to close packings of spheres |url=https://www.degruyter.com/document/doi/10.1515/zkri-2020-0013/html |journal=Zeitschrift für Kristallographie - Crystalline Materials |language=en |volume=235 |issue=8–9 |pages=255–261 |doi=10.1515/zkri-2020-0013 |s2cid=222005314 |issn=2196-7105|url-access=subscription }} |
|[RuNOPy4Br]4[Sb2Br8][Sb3Br12]2
|monoclinic |P21/c |a=12.021 b=22.454 c=26.372 β=92.506° Z=8 |7112 |2.634 |light orange |
1,4-bis(ammoniomethyl)cyclohexane
|(C8H20N2)2AgMBr8 |triclinic |P{{overbar|1}} |a 8.0820 b 8.161 c 11.814 α 90.185° β 95.390° γ 90.121° | | |band gap 2.600 eV |
histammonium
|(HIS)2AgSbBr8 |monoclinic |C2/c |a=11.5632 b=12.2529 c=18.694 β=94.264 Z=4 |2641.3 |2.754 |semiconductor; pale yellow |
|Cs3Sb2Br9
| | |a=7.9165 c=9.7139 | | |yellow; orange at 300°C; perovskite |
|Cs4Sb2Br12
|tetragonal |I41/amd |a=10.842 c=21.913 Z=2 |2576 | |black @300K |{{Cite journal |last1=Combs |first1=Victoria E. |last2=Oswald |first2=Iain W. H. |last3=Neilson |first3=James R. |date=2019-07-03 |title=Hydrothermal Crystal Growth of Mixed Valence Cs 2 SbBr 6 |url=https://pubs.acs.org/doi/10.1021/acs.cgd.9b00481 |journal=Crystal Growth & Design |language=en |volume=19 |issue=7 |pages=4090–4094 |doi=10.1021/acs.cgd.9b00481 |s2cid=191147344 |issn=1528-7483|url-access=subscription }} |
|Cs2AgSbBr6
|cubic |Fm{{overbar|3}}m |a = 11.1583 Z=4 |1389.2 |4.661 |black; bandgap 1.64 eV |
Benzeneethanammonium
|(C8NH12)4Bi0.57Sb0.43Br7⋅H2O |triclinic |P{{overbar|1}} |a=13.0207 b=13.1304 c=13.3192 α=93.818° β=102.408° γ=108.610° Z=2 |2085.1 |1.971 |light green |